Clinical Trials

Back to Trials

Australia Becomes Second Country to Approve Ocrelizumab for Primary Progressive MS

Type of Study/Intervention

Recruitment Status

Form of MS

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search